SynthesisAmerican journal of clinical dermatology2025
Ethnic Differences of Palmoplantar Pustulosis: A Systematic Review.
Synthesis in American journal of clinical dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The Relative Efficacy of Monotherapies for Palmoplantar Pustulosis and Palmoplantar Psoriasis: A Network Meta-Analysis Study of the Palmoplantar Spectrum.Medicina (Kaunas, Lithuania) · 2026Review
- SAPHO syndrome and pustular skin diseases: shared inflammatory circuits, divergent tissue outcomes, and the limits of a spectrum model.Frontiers in immunology · 2026Review
- IL-4Rα antagonist (Stapokibart) in refractory palmoplantar pustulosis: a case report and literature review of Th2-targeted therapies.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEthnic differences in the clinical and molecular features of many immune-mediated dermatoses have been reported, including psoriasis vulgaris and generalized pustular psoriasis. Palmoplantar pustulosis (PPP) is a chronic and relapsing inflammatory skin disease manifesting as crops of sterile pustules over an erythematous base on the palms and soles. To date, ethnic differences in PPP have been rarely studied.
objectivesTo compare the differences in epidemiology, genetic background, clinical manifestations, treatment patterns, and responses among patients with PPP across different ethnicities.
methodsA systematic review was performed in accordance with the 2020 PRISMA guidelines, including a search across four bibliographical databases, including articles published between the earliest available date until 1 February 2025. Articles were reviewed independently by two assessors. Any discrepancies were addressed and resolved through discussion. A narrative synthesis was performed owing to heterogeneity. The study protocol was registered in INPLASY (INPLASY202530108). No funding was received.
resultsOf 2250 studies screened, 101 studies were included. Among them, 46 studies (42 cohort studies, 1 case-control, and 3 case series) involving 216,257 patients described the clinical characteristics of PPP, with 13 and 14 cohort studies reporting on the epidemiological data and treatment type/response of PPP, respectively. Incidence and prevalence rates of PPP were higher among East Asians, especially in Japanese populations. While PPP is a female-predominant disease worldwide, more men are affected in Asia, likely owing to a lower prevalence of smoking among Asian females. Mutations in IL36RN, CARD14, and different HLA alleles contribute to the genetic landscape of PPP across ethnicities. PPP with preceding vesicles (type A) seemed more common in Asians, and type B (without preceding vesicles) is more common in non-Asians. Asians with PPP had less concurrent psoriasis vulgaris and psoriatic arthritis, as well as lower rates of smoking, obesity, celiac disease, and thyroid disease, while metal allergies were more common. Plantar-only or unilateral involvement were more frequent in non-Asians, whereas nail involvement and synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome/pustulotic arthro-osteitis (PAO) were more common in Asians. Among conventional treatment modalities, acitretin, colchicine, and tonsillectomy seemed more effective for Asians. Biologics were less commonly used in Asia, with ethnic-related differences in treatment response noted across classes.
conclusionsThis systematic review illustrated notable differences in genetic profiles, clinical features, and therapeutic responses of PPP across ethnicities. Although limited by study size and heterogeneity, these findings could enhance our understanding of ethnic-specific PPP traits. Thus, incorporating ethnic differences is crucial for effective diagnosis, genetic testing, and tailored management strategies in patients with PPP.
Indexed as
Identifiers
40888828What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.